PT-112 in mCRPC (Phase 2 expansion; Phosplatin Therapeutics)

Clinical Trial Grant

Duke Scholars

Principal Investigator Christopher Hoimes Medicine, Medical Oncology

Awarded By

Promontory Therapeutics

Start Date

July 11, 2022

End Date

December 31, 2026

Awarded By

Promontory Therapeutics

Start Date

July 11, 2022

End Date

December 31, 2026